Origins, Development, Current Challenges and Future Directions with Activated Prothrombin Complex Concentrate for the Treatment of Patients with Congenital Haemophilia with Inhibitors

Congenital haemophilia A (HA) is caused by deficiency of coagulation factor VIII (FVIII) activity, leading to spontaneous or traumatic bleeding events. While FVIII replacement therapy can treat and prevent bleeds, approximately 30% of patients with severe HA develop inhibitor antibodies that render...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Hamostaseologie
Main Authors: Brackmann, Hans H., Schramm, Wolfgang, Oldenburg, Johannes, Cano, Viridiana, Turecek, Peter L., Négrier, Claude
Format: Artigo
Jezik:Inglês
Izdano: Georg Thieme Verlag KG 2020
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7772007/
https://ncbi.nlm.nih.gov/pubmed/32717751
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1055/a-1159-4273
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki